Die Studie
Clinical trial of a new compound that is being developed for the treatment of cardiovascular diseases.
- You are a healthy male or female.You are at least 18 and no more than 64 years old .
- Your Body Mass Index (BMI) is higher or equal to 18.5 and lower or equal to 29.9 kg/m2. T
- Both non-smokers and light or occasional smokers are allowed to participate in this clinical trial. During your visits in our research facility you are not allowed to smoke.
Note:
- You cannot participate in the trial if you have participated in another clinical trial in the 30 days prior to the screening of this clinical trial (counting from the follow-up visit of the previous trial).
- To determine if you are suitable to participate in this trial, you will undergo a medical screening. Depending on availability, this can be performed in Groningen or in Utrecht.
As a female you can only participate if you are not pregnant, not breast feeding, and meet one of the following conditions:
- You use contraception (for example the contraceptive pill or intra-uterine device) in combination with a condom;
- You have passed the menopause (no periods for at least 12 months);
- You have been sterilized or your male partner has been sterilized;
- You are only sexually active with a female;
- You are not sexually active according to your lifestyle.
For males, there are no requirements regarding contraception.
Zeitraum
- The trial consists of a total of 14 short visits, so there is no overnight stay in the research facility in Groningen. After that, the follow-up visit will take place.
Actual study data:
www.iconarzneimittelforschung.de/ueber-pra/die-studien/pra-22307x
Aufwandsentschädigung
- You will receive a gross compensation of € 4034 for full participation.
Travel expenses will be reimbursed based on the distance traveled (€ 0,21 net per kilometer) with a minimum of € 13 and a maximum of € 176,40 (840 kilometers) per round trip, regardless of the mode of transportation.
